Evidence map›Paper›PMID 29080909›Full record

Observational studyClinical research in cardiology : official journal of the German Cardiac Society2018

Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.

Matthieu Legrand, Pierre-Olivier Ludes, Ziad Massy, Patrick Rossignol, Jiri Parenica, Jin-Joo Park, Shiro Ishihara, Khalid F AlHabib, Aldo Maggioni, Òscar Miró and 14 more

Open access · greenAbstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical research in cardiology : official journal of the German Cardiac Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Serum potassium dynamics during acute heart failure hospitalization.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Article
  8. Prognostic impact of potassium levels in patients with ventricular tachyarrhythmias.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  9. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 10 countries.

Matthieu LegrandDepartment of Anesthesiology and Critical Care and Burn Unit, St-Louis Hospital, Assistance Publique- Hôpitaux de Paris,, Paris, France. matthieu.legrand@aphp.fr.ORCID http://orcid.org/0000-0001-9788-5316
Pierre-Olivier LudesDepartment of Anesthesiology and Critical Care and Burn Unit, St-Louis Hospital, Assistance Publique- Hôpitaux de Paris,, Paris, France.
Ziad MassyDivision of Nephrology, Ambroise Paré university hospital, APHP, University of Paris Ouest-Versailles-St-Quentin-en-Yvelines (UVSQ), Boulogne-Billancourt, Paris, France.
Patrick RossignolINSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Jiri ParenicaDepartment of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic.
Jin-Joo ParkDivision of Cardiology, Department of Internal Medicine, Cardiovascular Center, Seoul National University Bundang Hospital, Seoul, South Korea.
Shiro IshiharaNippon Medical School Musashi-Kosugi Hospital, Kanagawa, Japan.
Khalid F AlHabibDepartment of Cardiac Sciences, College of Medicine, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia.
Aldo MaggioniANMCO Research Center, Firenze, Italy.
Òscar MiróEmergency Department, Hospital Clinic, and 'Emergency care: processes and diseases' Research Group, IDIBAPS, Barcelona, Catalonia, Spain.
Naoki SatoNippon Medical School Musashi-Kosugi Hospital, Kanagawa, Japan.
Alain Cohen-SolalDepartment of Cardiology, Hôpitaux Universitaire Saint Louis-Lariboisière, Assistance Publique des Hôpitaux de Paris, Paris, France.
Enrique FairmanSociedad Argentina de Cardiologia, Area de Investigacion SAC Azcuenaga, Buenos Aires, Argentina.
Johan LassusCardiology, Helsinki University and Helsinki University Hospital, Heart and Lung Center, Helsinki, Finland.
Veli-Pekka HarjolaCardiology, Helsinki University and Helsinki University Hospital, Heart and Lung Center, Helsinki, Finland.
Christian MuellerDepartment of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland.
Franck W PeacockBaylor College of Medicine, Houston, TX,, USA.
Dong-Ju ChoiDivision of Cardiology, Department of Internal Medicine, Cardiovascular Center, Seoul National University Bundang Hospital, Seoul, South Korea.
Patrick PlaisanceEmergency Department, Hôpitaux Universitaire Saint Louis-Lariboisière, Assistance Publique des Hôpitaux de Paris, Paris, France.
Jindřich SpinarDepartment of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic.
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas, MO, USA.
Alexandre MebazaaDepartment of Anesthesiology and Critical Care and Burn Unit, St-Louis Hospital, Assistance Publique- Hôpitaux de Paris,, Paris, France.
Etienne GayatDepartment of Anesthesiology and Critical Care and Burn Unit, St-Louis Hospital, Assistance Publique- Hôpitaux de Paris,, Paris, France.
GREAT (Global Research on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists) network
Inserm · FRHelsinki University Hospital · FIMasaryk University · CZNippon Medical School Musashi Kosugi Hospital · JPSeoul National University Bundang Hospital · KRAssistance Publique – Hôpitaux de Paris · FRAssociazione Nazionale Medici Cardiologi Ospedalieri · ITBaylor College of Medicine · USHospital Clínic de Barcelona · ESKing Saud University · SASaint Luke's Hospital · USUniversité Paris-Sud · FRUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe interaction between chronic medications on admission and the association between serum potassium level and outcome in patients with acute heart failure (AHF) are unknown.

methodsObservational intercontinental study of patients admitted with AHF. 15954 patients were included from 12 cohorts in 4 continents. Main outcome was 90-day mortality. Clinical presentation (medication use, hemodynamics, comorbidities), demographic, echocardiographic, and biochemical data on admission were recorded prospectively in each cohort, with prospective adjudication of outcomes.

resultsPositive and negative linear relationships between 90-day mortality and sK+ above 4.5 mmol/L (hyperkalemia) and below 3.5 mmol/L (hypo-kalemia) were observed. Hazard ratio for death was 1.46 [1.34-1.58] for hyperkalemia and 1.22 [1.06-1.40] for hypokalemia. In a fully adjusted model, only hyperkalemia remained associated with mortality (HR 1.03 [1.02-1.04] for each 0.1 mmol/l change of sK+ above 4.5 mmol/L). Interaction tests revealed that the association between hyperkalemia and outcome was significantly affected by chronic medications. The association between hyperkalemia and mortality was absent for patients treated with beta blockers and in those with preserved renal function.

conclusionsIn patients with AHF, sK+ > 4.5 mmol/L appears to be associated with 90-day mortality. B-blockers have potentially a protective effect in the setting of hyperkalemia.

Indexed as

Acute DiseaseAdrenergic beta-AntagonistsAgedAged, 80 and overBiomarkersEuropeFemaleFollow-Up StudiesHeart FailureHumansHyperkalemiaHypokalemiaMaleMiddle AgedPotassiumProspective StudiesAdrenergic beta-AntagonistsBiomarkersPotassiumB-blockersHeart failureMortalityPotassiumRenal failure

Identifiers

PMID29080909
OpenAlexW2765173003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.